Apnimed, Inc.
- Last sale
- Nov 12, 2026 · -0.27%
- Market cap
- $694.61M
- 41.63M shares
- Filings
- 61
Q2 2026
—Q2 2026
—Q2 2026
——
—
—Q2 2026
—Q2 2026
—- $694.61M
- —
- —
- —
- —
- —
FY2026 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
No annual history for this metric yet.
| Period | Ended | Value | Kind | Source trail |
|---|
Pharmaceutical preparations
Apnimed, Inc. is the 162nd largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
NVCTNuvectis Pharma, Inc.———$695.5M
APMDApnimed, Inc. (this company)———$694.6M
KURAKura Oncology, Inc.$67.5M25.2%412.9%$682.7MDSGNDesign Therapeutics, Inc.$0.0——$678.5MIMMXImmix Biopharma, Inc.———$677.2MAVBPArriVent BioPharma, Inc.———$675.8MBCAXBicara Therapeutics Inc.———$671.8MZVRAZevra Therapeutics, Inc.$106.5M350.9%78.2%$663.8MOLMAOlema Oncology, Inc.———$658.8MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Apnimed, Inc. · CIK 1745648 · Engraved from SEC EDGAR